Skip to Main Content
Share
Help
Email
Print
Close Window
National Coverage Analysis (NCA) for Positron Emission Tomography (FDG) for Alzheimer's Disease/Dementia (CAG-00088N)
Contact(s)
Stuart Caplan
stuart.caplan@cms.hhs.gov
410-786-8564
Back to Top
Documents
Tracking Sheet
Technology Assessment for Use of Positron Emission Tomography and Other Neuroimaging Techniques in the Diagnosis and Treatment of Alzheimer's Disease and Dementia
Decision Memo
NCD for Positron Emission Tomography (PET) Scans (220.6)
NCD for FDG PET for Dementia and Neurodegenerative Diseases (220.6.13)
NCD for Positron Emission Tomography (FDG) for Oncologic Conditions (220.6.17)
MEDCAC Meeting for Positron Emission Tomography (FDG) for Alzheimer's Disease/Dementia (Diagnostic Imaging Panel)
MEDCAC Meeting for Positron Emission Tomography (FDG) for Alzheimer's Disease/Dementia (Executive Committee)
Back to Top
History of Considerations
Original Consideration for Positron Emission Tomography (FDG) for Alzheimer's Disease/Dementia (this document)
First reconsideration for Positron Emission Tomography (FDG) and Other Neuroimaging Devices for Suspected Dementia (CAG-00088R)
Back to Top
Footer Links
Get Help with File Formats and Plug-Ins
Submit Feedback
www
